Among these situations, the antiphospholipid syndrome (APS) is the one that most closely resembles what happens in COVID-19 [8,9], which has led to the study of the presence of antiphospholipid antibodies (aPL) in these patients [10,11,12]. The gene discussed is FASLG; the disease is antiphospholipid syndrome.